首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Current cardiology reviews

缩写:

ISSN:1573-403X

e-ISSN:1875-6557

IF/分区:2.4/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引955
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Gayatri Khuntia,Jeevan Ranjan Dash Gayatri Khuntia
Introduction: Arsenic trioxide is a highly effective chemotherapeutic agent that counteracts acute promyelocytic leukemia. However, the use of arsenic trioxide for managing acute promyelocytic leukemia has been associated...
Sasan Shafiei,Roozbeh Narimani Javid,Negar Haratian et al. Sasan Shafiei et al.
Recent progress in unraveling the molecular mechanisms of infiltrative Cardiomyopathies (CMPs) has created exciting opportunities for targeted therapies. These conditions, which include cardiac amyloidosis, sarcoidosis, Danon disease, Fabry...
Francisco Epelde Francisco Epelde
Introduction: Chronic heart failure (CHF) represents a major global health burden. This review explores the potential of artificial intelligence (AI) in improving its diagnosis, treatment, and management. ...
Zuhair Amir Alkatiri,Muhammad Dzaky Erlangga Mumtaz,Muhammad Hatta Hakim et al. Zuhair Amir Alkatiri et al.
Introduction: The Zero-Fluoroscopy (ZF) approach has emerged as an alternative technique for transcatheter ventricular septal defect (VSD) closure, eliminating radiation exposure by relying solely on echocardiographic gui...
Zhuhua Wang,Shupeng Chen,Guilian He et al. Zhuhua Wang et al.
Introduction: Decreased Cardiac Ejection Function (DCEF) is a critical manifestation of cardiotoxicity and has been increasingly recognized as a potential adverse effect of pharmacotherapy, particularly with antineoplasti...
Hashim Talib Hashim,Mohammedbaqer Ali Al-Ghuraibawi,Muhammad Hassan Hafeez et al. Hashim Talib Hashim et al.
Introduction: Chronic heart failure (CHF) remains a leading cause of global morbidity and mortality, frequently resulting in hospitalizations and diminished quality of life. Sacubitril/ Valsartan, the first angiotensin re...
Roshni Singh,Bhumi Chaturvedi,Hemant Bareth et al. Roshni Singh et al.
Background: Cardiovascular diseases (CVDs) are a major global health burden with increasing prevalence rates and high morbidity and mortality rates. CVD has a variety of clinical and lifestyle risk factors, including, but...
Maria Petridou,Giorgios Mitsiou,Dimitrios Farmakis et al. Maria Petridou et al.
Background: Cardiopulmonary exercise testing (CPET) is the gold standard for assessing functional capacity in heart failure (HF). Oxygen kinetics during the early recovery phase, particularly the VO₂/t-slope (the linear ...
Anupama B C,Sheela N Rao,Manjappa M et al. Anupama B C et al.
Introduction: Cardiovascular diseases (CVDs) remain the leading cause of global mortality, with congenital heart disease (CHD), acquired heart disease (AHD), valvular disorders, and cardiomyopathies contributing significa...
Panagiota Spyropoulou,Panagiotis Theofilis,Petros G Mantzios et al. Panagiota Spyropoulou et al.
Introduction: Transcatheter patent foramen ovale (PFO) closure is the treatment of choice in younger patients with cryptogenic stroke or high-risk PFO features. A common complication post-procedurally is atrial fibrillati...